Cite
HARVARD Citation
Lim, H. et al. (n.d.). 2022-RA-1504-ESGO Tamoxifen-megestrol acetate combination hormonal therapy is an effective fertility-sparing treatment in early-stage endometrial cancer patients who have failed progestin only hormonal therapy. International journal of gynecological cancer. pp. A154-A155. [Online].